<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:blogger='http://schemas.google.com/blogger/2008' xmlns:georss='http://www.georss.org/georss' xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-1491854025099953429</id><updated>2016-05-20T01:23:04.667-07:00</updated><category term="ctic"/><category term="stock market"/><category term="GNBT"/><category term="Cell Therapeutics"/><category term="stocks"/><category term="LVS"/><category term="fnm"/><category term="Citigroup"/><category term="PPHM"/><category term="hot stocks"/><category term="Advanta"/><category term="CHCI"/><category term="HYTM"/><category term="Las Vegas Sands"/><category term="investing"/><category term="stock watch"/><category term="ADVNA"/><category term="C"/><category term="CTIC  GNBT  HYTM"/><category term="DOW"/><category term="Dendreon"/><category term="FRE"/><category term="Generex"/><category term="INTC"/><category term="INUV"/><category term="JPM"/><category term="KOW"/><category term="Monday stocks"/><category term="Oral-lyn"/><category term="Pre-market update"/><category term="RNN"/><category term="Russell Index"/><category term="alert"/><category term="banks"/><category term="earnings"/><category term="fannie mae"/><category term="financial"/><category term="hot stock"/><category term="missing child"/><category term="missing girl"/><category term="penny stocks"/><category term="pre-market volume"/><category term="profit"/><category term="reverse split"/><category term="six"/><category term="six flags"/><category term="sixf"/><category term="stock to watch"/><category term="stocks for the week"/><category term="volume"/><title type='text'>My investor&#39;s blog</title><subtitle type='html'>Investing is a great income opportunity.  It is also the key to a healthy retirement.  Come and read some ideas and share some ideas on my investor&#39;s blog. However I do not guarantee profits for any stock I discuss. These are companies that I believe are worth looking into.  The stock market has a great income potential but it also has a big risk factor.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default?start-index=26&amp;max-results=25'/><author><name>Dawn Conklin</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>38</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-1921681997778034774</id><published>2009-12-03T07:10:00.000-08:00</published><updated>2009-12-03T07:10:48.790-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Generex"/><category scheme="http://www.blogger.com/atom/ns#" term="GNBT"/><category scheme="http://www.blogger.com/atom/ns#" term="Oral-lyn"/><title type='text'>Generex Oral-lyn found to be safe in study</title><content type='html'>Generex Biotechnology (GNBT) has announced that a study finds Oral-lyn to be safe, effective and may reduce complications of insulin dependent diabetes.  Full story on CNN, &lt;a href=&quot;http://money.cnn.com/news/newsfeeds/articles/globenewswire/179533.htm&quot;&gt;click here&lt;/a&gt; to read the announcement.  They also announced on Tuesday that 256 drug stores in NYC will be carrying their Crave NX 7-day diet aid spray.  This will be available across NYC soon.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/1921681997778034774/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/12/generex-oral-lyn-found-to-be-safe-in.html#comment-form' title='3 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/1921681997778034774'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/1921681997778034774'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/12/generex-oral-lyn-found-to-be-safe-in.html' title='Generex Oral-lyn found to be safe in study'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-7060762046335236827</id><published>2009-11-11T06:29:00.000-08:00</published><updated>2009-11-11T06:35:16.152-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Cell Therapeutics"/><category scheme="http://www.blogger.com/atom/ns#" term="ctic"/><title type='text'>Cell Therapeutics</title><content type='html'>I have been following Cell Therapeutics (CTIC) since the beginning of 2009.  When I first posted them as a buy they were in the 30 cent range and they had gone as high as $1.85.  When they got to the $1.40 range I expressed my concern about holding them as a recommendation to sell and they shortly went into the 90 cent range.  Now they are holding around $1 but I would watch out for them in the next couple of months as Pixantrone is up for approval decision in April and this could bring in a nice profit.  I cannot guarantee a profit with any stock and I cannot guarantee that Pixantrone will be approved however I do not see any reason that it will not be approved.  I believe that Cell Therapeutics (CTIC) has hit their low.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/7060762046335236827/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/11/cell-therapeutics.html#comment-form' title='2 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/7060762046335236827'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/7060762046335236827'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/11/cell-therapeutics.html' title='Cell Therapeutics'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>2</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-180185332294897885</id><published>2009-11-09T17:59:00.000-08:00</published><updated>2009-11-09T18:04:46.353-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="CHCI"/><category scheme="http://www.blogger.com/atom/ns#" term="profit"/><category scheme="http://www.blogger.com/atom/ns#" term="stock to watch"/><title type='text'>CHCI posts profit</title><content type='html'>Comstock Home Building Companies (CHCI) is a company to keep an eye.  They returned to profit in their 3rd quarter and they already went up 30% after the news.  Keep an eye on this stock for tomorrow morning and for time to come.  &lt;br /&gt;I do not guarantee a profit from any stock but I do think this is a stock to look into.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/180185332294897885/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/11/chci-posts-profit.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/180185332294897885'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/180185332294897885'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/11/chci-posts-profit.html' title='CHCI posts profit'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-2345937187416046416</id><published>2009-11-02T20:32:00.000-08:00</published><updated>2009-11-02T20:43:05.099-08:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="GNBT"/><category scheme="http://www.blogger.com/atom/ns#" term="HYTM"/><title type='text'>Keep an eye out on Generex (GNBT)</title><content type='html'>Keep an eye on Generex Biotechnology (GNBT).  I have talked about them in the past but I think they are at their bottom now and they have a great pipeline of products.  I am not positive but I think there will be some good news in the near future.  Lately the only news they have had has been good. I am holding long position on these guys.&lt;br /&gt; &lt;br /&gt;I am keeping an eye on Hythiam (HYTM) still as well.  I currently do not own them but they have a great potential with their PROMETA program and their contract with Ford.  They have been going down lately however this is probably their bottom.  They have a couple of possible contracts to be made, though I cannot say they will get these contracts but with Ford on board I am sure they will get more contracts soon.  They have not released any news for a while and I think they will start having good news again soon.  I would keep an eye out on these two stocks.&lt;br /&gt;It has been a crazy market lately and these are the two that I think are worth looking into.  I haven&#39;t had other stocks really stand out to me lately, at least not small cap stocks.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/2345937187416046416/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/11/keep-eye-out-on-generex-gnbt.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/2345937187416046416'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/2345937187416046416'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/11/keep-eye-out-on-generex-gnbt.html' title='Keep an eye out on Generex (GNBT)'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-2044240313338534992</id><published>2009-10-16T21:28:00.000-07:00</published><updated>2009-10-16T21:34:01.780-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="PPHM"/><category scheme="http://www.blogger.com/atom/ns#" term="reverse split"/><title type='text'>Peregrine Pharmaceuticals reverse split</title><content type='html'>Peregrine Pharmaceuticals (PPHM) has announced they will be implementing a 1:5 reverse stock split on October 19th.  This is to avoid being delisted from Nasdaq as they must bring their price up or face delisting next month.  This was voted upon last year by stockholders as a last resort before delisting.  They had announced it today they will be implementing it.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/2044240313338534992/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/10/peregrine-pharmaceuticals-reverse-split.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/2044240313338534992'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/2044240313338534992'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/10/peregrine-pharmaceuticals-reverse-split.html' title='Peregrine Pharmaceuticals reverse split'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-8991009874783848572</id><published>2009-10-14T10:58:00.000-07:00</published><updated>2009-10-14T11:03:09.922-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="DOW"/><category scheme="http://www.blogger.com/atom/ns#" term="INTC"/><category scheme="http://www.blogger.com/atom/ns#" term="JPM"/><title type='text'>Dow touched 10,000</title><content type='html'>The DOW jumped up and saw 10,001 today.  This is the highest the DOW has been this year.  JP Morgan Chase (JPM) had released much higher then expected earnings and Intel(INTC) had impressive earnings as well which is to thank for the nice climb up today.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/8991009874783848572/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/10/dow-touched-10000.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/8991009874783848572'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/8991009874783848572'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/10/dow-touched-10000.html' title='Dow touched 10,000'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-611998124603715246</id><published>2009-10-14T06:30:00.000-07:00</published><updated>2009-10-14T06:35:14.715-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="GNBT"/><title type='text'>Generex to hold conference call</title><content type='html'>Generex (GNBT) is holding a conference call Thursday October 15th at 11:00 am EST to update inestors on their drug Oral-lyn and other corporate activities.  I am expecting their price to go up on the news but do not guarantee it.  I think Oral-lyn will be a big drug once released.  It was given the ok for IND by the FDA last month but once approved for release it should be an effective drug to treat diabetes.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/611998124603715246/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/10/generex-to-hold-conference-call.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/611998124603715246'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/611998124603715246'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/10/generex-to-hold-conference-call.html' title='Generex to hold conference call'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-6416057562331404255</id><published>2009-10-05T11:45:00.000-07:00</published><updated>2009-10-05T11:53:16.838-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="CTIC  GNBT  HYTM"/><title type='text'>Stock update</title><content type='html'>It has been a while since I have posted here I know.  I have been up in the air with many stocks and recently have been a little disappointed with Cell Therapeutics (CTIC).  They have withdrawn the MMA for Opaxio and yes it seems they will be pursuing it more for ovarian cancer however I think it is very odd that they didn&#39;t try to figure which was the best thing Opaxio was good for before submitting a MMA.  I also started having my doubts since Pixantrone was not granted priority review.&lt;br /&gt;&lt;br /&gt;Hythiam (HYTM) is a company I am expecting to see a gain in the near future.  They have a good treatment program and have their 3 year contract with Ford Motor Company (F).  I believe there will be more contract announcements in the near future.  I do not guarantee a profit on this or any stock personally.&lt;br /&gt;&lt;br /&gt;Generex (GNBT) was awarded approval of use of Oral lyn for IND last month.  They will be reporting earnings tonight at 6 PM.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/6416057562331404255/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/10/stock-update.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/6416057562331404255'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/6416057562331404255'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/10/stock-update.html' title='Stock update'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-542005627417398156</id><published>2009-09-17T18:32:00.000-07:00</published><updated>2009-09-17T18:38:21.510-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Cell Therapeutics"/><category scheme="http://www.blogger.com/atom/ns#" term="ctic"/><title type='text'>Cell Therapeutics</title><content type='html'>Cell Therapeutics (CTIC) is a company that everybody has heard me speak alot about.  They were only given standard review by the FDA for the drug Pixantrone however they just released positive data from their phase III follow up.  They also will be hearing by October 2nd if their drug Opaxio will be approved for marketing in Europe.  The news can actually come any day now.  Pixantrone still has great potential to bring this stock up it&#39;s just the date is set to April 2010 instead of December 2009.  It appears to be a great drug and should do well.  For the shorter term though we are waiting on the news about Opaxio.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/542005627417398156/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/09/cell-therapeutics.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/542005627417398156'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/542005627417398156'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/09/cell-therapeutics.html' title='Cell Therapeutics'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-7543761538457702044</id><published>2009-09-17T18:22:00.000-07:00</published><updated>2009-09-17T18:32:31.324-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="HYTM"/><title type='text'>A stock to keep an eye on</title><content type='html'>I recently noticed a company Hythiam (HYTM) and it was honestly bought on a spur of the moment day trade to make quick money.  However shortly after I bought it the stock went down just a little and then evened out right around where I bought it at.  I did start to get a little antsy on this one as they did receive a delisting notice from Nasdaq and had to show them a plan to regain compliance.  Well I was hanging in there hoping it would go up enough just to make a profit or well I was even shooting for breaking even.  I knew they had great potential but it was a matter of any of their contracts getting signed before being delisted.  Today they released a PR stating their contract with Ford Motor Company for the employee substance abuse program.  This was what I was looking for!  Now they should be able to regain compliance.  They have a couple other contracts in the works which I am sure will go through now that Ford entered a contract.  We are not talking about a no name business here.  Keep your eye on HYTM and do your own research.  Investing in any stock is risky and this company is risky as well but I see they have potential now.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/7543761538457702044/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/09/stock-to-keep-eye-on.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/7543761538457702044'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/7543761538457702044'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/09/stock-to-keep-eye-on.html' title='A stock to keep an eye on'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-2454043102198898100</id><published>2009-08-24T04:46:00.000-07:00</published><updated>2009-08-24T04:48:58.471-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="ctic"/><title type='text'>FDA accepts NDA for Pixantrone</title><content type='html'>FDA accepted Cell Therapeutics (CTIC) NDA for the drug Pixantrone.  FDA opts for standard review.  Cell Therapeutics to discuss merits for a priority review and the final decision is due September 4th.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/2454043102198898100/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/08/fda-accepts-nda-for-pixantrone.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/2454043102198898100'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/2454043102198898100'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/08/fda-accepts-nda-for-pixantrone.html' title='FDA accepts NDA for Pixantrone'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-316426747261054596</id><published>2009-08-23T20:15:00.000-07:00</published><updated>2009-08-23T20:21:22.743-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="CHCI"/><category scheme="http://www.blogger.com/atom/ns#" term="ctic"/><category scheme="http://www.blogger.com/atom/ns#" term="fnm"/><category scheme="http://www.blogger.com/atom/ns#" term="FRE"/><title type='text'>Monday alerts</title><content type='html'>Keep an eye on Comstock Homebuildings Inc (CHCI) tomorrow.  They were on the move on Friday, at one point they more then doubled and then closed up 30 cents.  They are one to keep a lookout for tomorrow.  Also Cell Therapeutics (CTIC) should be hearing from the FDA tomorrow about if their priority review was granted for Pixantrone.&lt;br /&gt;Fannie Mae (FNM) was on the move as so was Freddie Mac (FRE.)  I would keep an eye on them this week as more housing data comes in this week.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/316426747261054596/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/08/monday-alerts.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/316426747261054596'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/316426747261054596'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/08/monday-alerts.html' title='Monday alerts'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-2849467420725439070</id><published>2009-08-06T05:21:00.000-07:00</published><updated>2009-08-06T05:25:57.112-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="ctic"/><category scheme="http://www.blogger.com/atom/ns#" term="fnm"/><title type='text'>Fannie Mae is on the move</title><content type='html'>Fannie Mae (FNM) has been on the move yesterday and again today.  In pre-market they are up 25%.  I recommend checking them out this morning.  I also think they will be announcing their dividends soon, I have not heard anything however this is about the time last year that they announced them.&lt;br /&gt;Cell Therapeutics (CTIC) should be receiving their approval for the priority review from the FDA soon.  I would be very surprised if they do not receive it.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/2849467420725439070/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/08/fannie-mae-is-on-move.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/2849467420725439070'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/2849467420725439070'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/08/fannie-mae-is-on-move.html' title='Fannie Mae is on the move'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-6230121215764241354</id><published>2009-07-28T20:22:00.000-07:00</published><updated>2009-07-28T20:50:41.830-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="ctic"/><category scheme="http://www.blogger.com/atom/ns#" term="GNBT"/><category scheme="http://www.blogger.com/atom/ns#" term="INUV"/><category scheme="http://www.blogger.com/atom/ns#" term="KOW"/><category scheme="http://www.blogger.com/atom/ns#" term="PPHM"/><title type='text'>Couple of stocks to look out for</title><content type='html'>Here are a couple of stocks that I would like to mention again.  Generex Biotechnology (GNBT), Cell Therapeutics (CTIC), Kowabunga Inc (KOW) and Peregrine Pharmaceutical (PPHM).  I have talked about these stocks a lot before however now is a good time to keep an eye on them.  Generex Biotechnology has a promising product line.  &lt;br /&gt;Cell Therapeutics (CTIC) should have the answer to their request for a priority review for their drug Pixantrone by August 24th in which I am sure they will receive priority review as it is a cancer drug.&lt;br /&gt;Kowabunga (KOW) will be releasing their new website and product August 10th.  Please note though that the close of business on July 30th will be the last day for them to trade under (KOW).  At the open on July 31st the company will be traded under (INUV), the company name will be changing to Inuvo, Inc &lt;a href=&quot;http://www.inuvo.com&quot;&gt;www.inuvo.com&lt;/a&gt; with the launch of their product.  There is no need to worry about share certificates with the old company name as they will still be valid. &lt;br /&gt;Peregrine Pharmaceuticals (PPHM) will present at the Jesup &amp; Lamont 2009 Growth Stock and National Sales Conference on July 30th.  The time is at 8:30 am EDT.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/6230121215764241354/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/07/couple-of-stocks-to-look-out-for.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/6230121215764241354'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/6230121215764241354'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/07/couple-of-stocks-to-look-out-for.html' title='Couple of stocks to look out for'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-3499647334867450868</id><published>2009-07-21T19:58:00.000-07:00</published><updated>2009-07-21T20:09:38.171-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="ctic"/><category scheme="http://www.blogger.com/atom/ns#" term="GNBT"/><title type='text'>Keep an eye on these two</title><content type='html'>Generex Biotechnology (GNBT) has released some good news about their pre-clinical data on a few vaccines including one for cervical cancer and the flu strands.  They are definitely a company to keep your eye on.  Not to mention they have gone up the last couple of days.&lt;br /&gt;Cell Therapeutics (CTIC) is the other one to keep an eye on.  They have been on my watch list for a while now.  They should hear from the FDA by late August about if they will be granted the priority review for Pixantrone which would put the drug on the market probably in late December.  They also released some good news regarding Brostallicin&#39;s anti-tumor effectiveness.  They too went up today.&lt;br /&gt;I wish I had seen Human Genome Sciences (HGSI) earlier for everybody.  I too missed out on it as I heard about them when they went up $9 in a day.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/3499647334867450868/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/07/keep-eye-on-these-two.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/3499647334867450868'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/3499647334867450868'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/07/keep-eye-on-these-two.html' title='Keep an eye on these two'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-3298090028567850378</id><published>2009-07-15T21:24:00.001-07:00</published><updated>2009-07-15T21:25:30.061-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="missing child"/><category scheme="http://www.blogger.com/atom/ns#" term="missing girl"/><title type='text'>Please help find a missing 11 year old girl!</title><content type='html'>Lindsey Baum was walking home on June 26th from a friends house but never made it home.  Her profile was shown on America&#39;s Most Wanted on July 11th.  I do not know her and live across the country from Washington State but I am helping to get the word out to as many people as I possibly can.  Here is a link to a webpage that has more information including pictures of her &lt;a href=&quot;http://www.squidoo.com/find-lindsey&quot;&gt;http://www.squidoo.com/find-lindsey&lt;/a&gt;.  I ask that you help spread the word to as many people as you can.  Thank you and our thoughts are on the family and their little girls safe return!</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/3298090028567850378/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/07/blog-post.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/3298090028567850378'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/3298090028567850378'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/07/blog-post.html' title='Please help find a missing 11 year old girl!'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-7115461162695080070</id><published>2009-07-02T07:46:00.000-07:00</published><updated>2009-07-02T07:54:33.520-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Cell Therapeutics"/><category scheme="http://www.blogger.com/atom/ns#" term="Russell Index"/><title type='text'>Cell Therapeutics was accepted in Russell Index</title><content type='html'>Cell Therapeutics has been accepted by the Russell Index.  They were added on the 29th of June.  This is a great step for them to re-establish themselves as a big corporation.  Their stock was once trading at $3000 a share back in 2000 and they traded at $300 a share about 5 years ago.  They finished the submission of NDA for Pixantrone in June and requested priority review.  This could put it out in the market during the 4th quarter.&lt;br /&gt;Keep these guys on a watch as I think they will be profitable.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/7115461162695080070/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/07/cell-therapeutics-was-accepted-in.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/7115461162695080070'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/7115461162695080070'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/07/cell-therapeutics-was-accepted-in.html' title='Cell Therapeutics was accepted in Russell Index'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-8179749432659480696</id><published>2009-06-27T18:08:00.000-07:00</published><updated>2009-06-27T18:12:04.802-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Cell Therapeutics"/><title type='text'>Cell Therapeutics</title><content type='html'>Cell Therapeutics (CTIC) was up on Friday.  They finished submission of the NDA a couple of days ago and requested a priority review, which if granted will put Pixantrone on the market in the fourth quarter of 2009.  Monday is when we will find out if they are accepted in the Russell Indexes which will greatly increase their value.  Look out for them on Monday!</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/8179749432659480696/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/06/cell-therapeutics.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/8179749432659480696'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/8179749432659480696'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/06/cell-therapeutics.html' title='Cell Therapeutics'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-4322294390772734706</id><published>2009-06-18T09:33:00.000-07:00</published><updated>2009-06-18T09:39:19.424-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Cell Therapeutics"/><category scheme="http://www.blogger.com/atom/ns#" term="ctic"/><title type='text'>Cell Therapeutics on my watch</title><content type='html'>Keep your eye on Cell Therapeutics (CTIC) in the next couple of weeks.  They have made the preliminary list for the Russell 3000 Index and the Russell Global Index.  Final decision is on June 26th.  I do not guarantee that this will make their stock go up and I do not guarantee they will make the Index however I recommend you keep your eye on them and do your own research on them before investing. Their financials are still a little rocky but they did get some of their note holders to take a deal so they could reduce some of their debt.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/4322294390772734706/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/06/cell-therapeutics-on-my-watch.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/4322294390772734706'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/4322294390772734706'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/06/cell-therapeutics-on-my-watch.html' title='Cell Therapeutics on my watch'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-6662797012719636786</id><published>2009-06-08T07:15:00.000-07:00</published><updated>2009-06-08T07:18:42.171-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="alert"/><category scheme="http://www.blogger.com/atom/ns#" term="stocks"/><title type='text'>Alert!!</title><content type='html'>Peregrine Pharmaceuticals (PPHM) is on the move today!&lt;br /&gt;Generex Biotechnology (GNBT) has had a high trading volume today they are on my watch.  &lt;br /&gt;But PPHM is on the up</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/6662797012719636786/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/06/alert.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/6662797012719636786'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/6662797012719636786'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/06/alert.html' title='Alert!!'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-5779438359609791396</id><published>2009-05-28T11:22:00.001-07:00</published><updated>2009-05-28T11:28:09.754-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="hot stock"/><category scheme="http://www.blogger.com/atom/ns#" term="PPHM"/><title type='text'>Important update</title><content type='html'>I was keeping an eye on this company yesterday and now today they have released some good news this morning.  They are now up 61%.  The name of the company is Peregrine Pharmaceuticals (PPHM) and they have released information about the clinical data on their drug Cotara.  It is a drug used for brain, liver and colon cancer.  The numbers were impressive and they will be announcing their clinical data at the Society of Nuclear Medicine Annual Meeting that will be held June 13-18.  I recommend checking them out and keeping an eye on them.&lt;br /&gt;However I do not guarantee a profit from investing in the company and you should understand the risks of investing before you do invest in them.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/5779438359609791396/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/05/important-update.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/5779438359609791396'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/5779438359609791396'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/05/important-update.html' title='Important update'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-5801220865725340587</id><published>2009-05-27T08:03:00.000-07:00</published><updated>2009-05-27T08:08:35.328-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="stocks"/><category scheme="http://www.blogger.com/atom/ns#" term="volume"/><title type='text'>Lot of volume on these two</title><content type='html'>On the move today we have Kowabunga! Inc. (KOW)  it has suddenly seen a lot of volume.  I would also recommend to keep your eye on Cell Therapeutics (CTIC) still.  They see alot of volume each day and released some of the phase III data for Pixantrone recently.&lt;br /&gt;These are my main two companies to watch out for so far today.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/5801220865725340587/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/05/lot-of-volume-on-these-two.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/5801220865725340587'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/5801220865725340587'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/05/lot-of-volume-on-these-two.html' title='Lot of volume on these two'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-199456075388225120</id><published>2009-05-18T06:06:00.000-07:00</published><updated>2009-05-18T06:18:54.800-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="pre-market volume"/><category scheme="http://www.blogger.com/atom/ns#" term="stocks"/><title type='text'>My stocks on watch with high volume in pre-market</title><content type='html'>Here are the stocks with high volume in pre market that I have had on alert:&lt;br /&gt;Cell Therapeutics(CTIC) is seeing a lot of pre-market volume.  I think they will be seeing an increase today at market&#39;s opening.  They announced closing an Italian facility to cut down operating costs.&lt;br /&gt;Las Vegas Sands (LVS)is seeing a nice volume and is going up in pre-market.  They haven&#39;t released any news about it yet however today is their first of two test days to be completed before they open the casino in Bethlehem on Friday May 22.&lt;br /&gt;Generex Biotechnology (GNBT) just started to see some volume in the pre-market and are showing the signs of going up a little today.  They have announced news that their oral insulin is available in Lebanon.&lt;br /&gt;&lt;br /&gt;I have not seen any pre-market trading on Rexahn Pharmaceuticals (RNN) yet however they have released news about their new depression drugs in a clinical trial.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/199456075388225120/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/05/my-stocks-on-watch-with-high-volume-in.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/199456075388225120'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/199456075388225120'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/05/my-stocks-on-watch-with-high-volume-in.html' title='My stocks on watch with high volume in pre-market'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-3587769398777647777</id><published>2009-05-14T06:23:00.000-07:00</published><updated>2009-05-14T06:29:22.819-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Pre-market update"/><title type='text'>Pre-Market  Update</title><content type='html'>An update:  Generex Biotechnology Corporation (GNBT) is on the move in the pre-market hours.  They too are a company I would keep an eye on today.  Cell Therapeutics (CTIC) has a high pre-market volume as well.  Las Vegas Sands (LVS) had lost more in the after hours trading last night however it is gaining it back in the pre-market trading this morning.&lt;br /&gt;This is the pre-market update on the stocks I have to watch for today.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/3587769398777647777/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/05/pre-market-update.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/3587769398777647777'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/3587769398777647777'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/05/pre-market-update.html' title='Pre-Market  Update'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-1491854025099953429.post-3640370890685144354</id><published>2009-05-14T05:56:00.000-07:00</published><updated>2009-05-14T06:05:44.316-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="ctic"/><category scheme="http://www.blogger.com/atom/ns#" term="LVS"/><category scheme="http://www.blogger.com/atom/ns#" term="RNN"/><category scheme="http://www.blogger.com/atom/ns#" term="stock watch"/><title type='text'>My Thursday Stock Watch</title><content type='html'>My Thursday morning hot stocks to keep a watch on include:&lt;br /&gt;Rexahn Pharmaceuticals (RNN)  They have 3 Phase II drugs currently.  These 3 drugs have the potential to be the best in the class.  Keep an eye on these guys within the next couple of days.&lt;br /&gt;&lt;br /&gt;Las Vegas Sands (LVS) They dropped down below the $9 mark after news that involved MGM Mirage.  However all the casinos dropped yesterday after this news.  Now is a good time to look at (LVS) as they are lower and should shortly rebound.&lt;br /&gt;&lt;br /&gt;Cell Therapeutics (CTIC) is still hovering in between the $1.20-$1.50 range.  They too are one that I would look into and keep your eye on.&lt;br /&gt;&lt;br /&gt;I do not guarantee any profit from any of these stocks and encourage you to research for yourself before investing into any of these stocks.</content><link rel='replies' type='application/atom+xml' href='http://myinvestors.blogspot.com/feeds/3640370890685144354/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://myinvestors.blogspot.com/2009/05/my-thursday-stock-watch.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/3640370890685144354'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/1491854025099953429/posts/default/3640370890685144354'/><link rel='alternate' type='text/html' href='http://myinvestors.blogspot.com/2009/05/my-thursday-stock-watch.html' title='My Thursday Stock Watch'/><author><name>Dawn Conklin</name><uri>https://plus.google.com/117820523431426859461</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-aL9LNL9n_X8/AAAAAAAAAAI/AAAAAAAABJo/atvTGPy0878/s512-c/photo.jpg'/></author><thr:total>0</thr:total></entry></feed>